Study 903 Design

• HIV RNA > 5000 copies/mL; no CD4 entry criteria

ART-naive patients

(N = 600)

randomized 1:1

144 wks

144 wks

Week 48

Interim Analysis

Previous slide

Next slide

Back to first slide

View graphic version